Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer

Strahlentherapie und Onkologie

Volumn 188, Issue 10, 2012, Pages 894-900

  Guckenberger, M ^a,b   Kavanagh, A ^b   Partridge, M ^b  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Adaptive radiotherapy; Intensity modulated radiotherapy; Non small cell lung cancer; Simultaneous integrated boost; Tumor control probability

Indexed keywords

CISPLATIN; NAVELBINE;

ADAPTIVE RADIATION; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; PATIENT CARE PLANNING; PATIENT SAFETY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION SAFETY; THERAPY EFFECT; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RISK ASSESSMENT;

EID: 84866689510     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0161-9     Document Type: Article

References (29)

1. Auperin A, Le Pechoux C, Rolland E et al (2010) Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 28:2181-2190
2. Boda-Heggemann J, Lohr F, Wenz F et al (2011) kV cone-beam CT-based IGRT: a clinical review. Strahlenther Onkol 187:284-291
3. Bortfeld T, Jokivarsi K, Goitein M et al (2002) Effects of intra-fraction motion on IMRT dose delivery: statistical analysis and simulation. Phys Med Biol 47:2203-2220
4. Brenner DJ (1993) Dose, volume, and tumor-control predictions in radiotherapy. Int J Radiat Oncol Biol Phys 26:171-179
5. Chapet O, Thomas E, Kessler ML et al (2005) Esophagus sparing with IMRT in lung tumor irradiation: an EUD-based optimization technique. Int J Radiat Oncol Biol Phys 63:179-187
6. Christian JA, Bedford JL, Webb S et al (2007) Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 67:735-741
7. De Gersem WR, Derycke S, Colle CO et al (1999) Inhomogeneous target-dose distributions: a dimension more for optimization? Int J Radiat Oncol Biol Phys 44:461-468
8. Feng M, Kong FM, Gross M et al (2009) Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. Int J Radiat Oncol Biol Phys 73:1228-1234
9. Fenwick JD, Nahum AE, Malik ZI et al (2009) Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement. Clin Oncol (R Coll Radiol) 21:343-360
10. Gillham C, Zips D, Ponisch F et al (2008) Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning? Radiother Oncol 88:335-341
11. Grills IS, Yan D, Martinez AA et al (2003) Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys 57:875-890
12. Grutters JP, Kessels AG, Pijls-Johannesma M et al (2010) Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. Radiother Oncol 95:32-40
13. Guckenberger M, Baier K, Richter A et al (2009) Evolution of surface-based deformable image registration for adaptive radiotherapy of non-small cell lung cancer (NSCLC). Radiat Oncol 4:68
14. Guckenberger M, Krieger T, Richter A et al (2009) Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy. Radiother Oncol 91:288-295
15. Guckenberger M, Richter A, Wilbert J et al (2011) Adaptive radiotherapy for locally advanced non-small-cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control. Int J Radiat Oncol Biol Phys 81:e275-e282
16. Guckenberger M, Richter A, Wilbert J et al (2011) Adaptive radiotherapy for locally advanced non-small cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control. IJROBP 81:e275-282
17. Guckenberger M, Wilbert J, Richter A et al (2011) Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 79:901-908
18. Kupelian PA, Ramsey C, Meeks SL et al (2005) Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: observations on tumor regression during treatment. Int J Radiat Oncol Biol Phys 63:1024-1028
19. Liao ZX, Komaki RR, Thames HD Jr et al (2010) Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys 76:775-781
20. Liu HH, Wang X, Dong L et al (2004) Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58:1268-1279
21. Martel MK, Ten Haken RK, Hazuka MB et al (1999) Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 24:31-37
22. Nakayama H, Satoh H, Kurishima K et al (2010) High-dose conformal radiotherapy for patients with stage III non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 78:645-650
23. Nguyen PL, Gu X, Lipsitz SR et al (2011) Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol 29:1517-1524
24. Palma D, Visser O, Lagerwaard FJ et al (2010) Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol 28:5153-5159
25. Ramsey CR, Langen KM, Kupelian PA et al (2006) A technique for adaptive image-guided helical tomotherapy for lung cancer. Int J Radiat Oncol Biol Phys 64:1237-1244
26. Schwarz M, Alber M, Lebesque JV et al (2005) Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 62:561-570
27. Sonke JJ, Lebesque Jvan Herk M (2008) Variability of four-dimensional computed tomography patient models. Int J Radiat Oncol Biol Phys 70:590-598
28. Tome WA, Fowler JF (2000) Selective boosting of tumor subvolumes. Int J Radiat Oncol Biol Phys 48:593-599
29. Wurstbauer K, Weise H, Deutschmann H et al (2010) Non-small cell lung cancer in stages I-IIIB: Long-term results of definitive radiotherapy with doses >/=80 Gy in standard fractionation. Strahlenther Onkol 186: 551-557